XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancers

被引：0

作者：

Hamilton, Erika ^{[1
]}

Spira, Alexander ^{[2
]}

Adams, Sylvia ^{[3
]}

Abuhadra, Nour ^{[4
]}

Giordano, Antonio ^{[5
]}

Parajuli, Ritesh ^{[6
]}

Han, Hyo ^{[7
]}

Weise, Amy ^{[8
]}

Marchesani, Aubri ^{[9
]}

Josephs, Kate ^{[9
]}

Chaudhry, Arvind ^{[10
]}

Kalinsky, Kevin ^{[11
]}

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] NEXT Oncol, Fairfax, VA USA

[3] NYU Langhone, Perlmutter Canc Ctr, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, New York, NY USA

[5] Dana Farber Canc Inst, Boston, MA USA

[6] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA

[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[8] Henry Ford Canc Inst, Detroit, MI USA

[9] Mersana Therapeut, Cambridge, MA USA

[10] Summit Canc Ctr, Spokane, WA USA

[11] Winship Canc Inst, Atlanta, GA USA

来源：

GYNECOLOGIC ONCOLOGY | 2023年 / 176卷

关键词：

D O I：

10.1016/j.ygyno.2023.06.159

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1250

引用

页码：S158 / S158

页数：1

共 50 条

[1] XMT-1660: A PHASE 1B TRIAL OF A B7-H4 TARGETING ANTIBODY DRUG CONJUGATE (ADC) IN ENDOMETRIAL, OVARIAN, AND BREAST CANCERS
Hamilton, Erika
Chaudhry, Arvind
Spira, Alex
Adams, Sylvia
Abuhadra, Nour
Giordano, Antonio
Parajuli, Ritesh
Han, Hyo
Weise, Amy
Marchesani, Aubri
Josephs, Kate
Im, Ellie
Shin, Chu Ri
Kalinsky, Kevin
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A228 - A229
[2] XMT-1660: A Phase 1b trial of a B7-H4 targeted Antibody Drug Conjugate (ADC) in Breast, Endometrial, and Ovarian Cancers
Hamilton, Erika
Chaudhry, Arvind
Spira, Alexander I.
Adams, Sylvia
Abuhadra, Nour
Giordano, Antonio
Parajuli, Ritesh
Han, Hyo S.
Weise, Amy
Marchesani, Aubri
Josephs, Kate
Shin, Chu Ri
Kalinsky, Kevin
CANCER RESEARCH, 2023, 83 (05)
[3] XMT-1660: A phase 1b trial of a B7-H4 targeted antibody drug conjugate (ADC) in breast, endometrial, and ovarian cancers
Hamilton, Erika P.
Chaudhry, Arvind
Spira, Alexander I.
Adams, Sylvia
Abuhadra, Nour
Giordano, Antonio
Parajuli, Ritesh
Han, Hyo S.
Weise, Amy M.
Marchesani, Aubri
Gupta, Divya
Josephs, Kate
Kalinsky, Kevin
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[4] XMT-1660: A phase I, first-in-human trial of a B7-H4-directed dolasynthen antibody-drug conjugate in ovarian, endometrial, and breast cancers
Burger, Robert
Hamilton, Erika
Adams, Sylvia
Han, Hyo
Spira, Alexander
Giordano, Antonio
Chaudhry, Arvind
Parajuli, Ritesh
Wang, Judy
Weise, Amy
Abuhadra, Nour
McNamara, Patrick
Kalinsky, Kevin
GYNECOLOGIC ONCOLOGY, 2024, 190 : S282 - S282
[5] XMT-1660, a B7-H4-targeted Dolasynthen antibody-drug conjugate for the treatment of breast cancer.
Fessler, Shawn P.
Wang, Jason
Collins, Scott D.
Qin, LiuLiang
Avocetien, Kenneth
Xu, Ling
Eydelloth, Ronald
Vonderfecht, Steven
Chin, Chen-Ni
Bradley, Steven
Clardy, Susan
Dirksen, Anouk
Ditty, Elizabeth
Du, Bingfan
Kim, Dokyong
Mosher, Rebecca
Ter-Ovanesyen, Elena
Slocum, Kelly
Uttard, Alex
Wongthida, Phonphimon
Zurita, Jeffrey
Toader, Dorin
Damelin, Marc
Lowinger, Timothy B.
CANCER RESEARCH, 2021, 81 (13)
[6] Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
Toader, Dorin
Fessler, Shawn P.
Collins, Scott D.
Conlon, Patrick R.
Bollu, Reddy
Catcott, Kalli C.
Chin, Chen-Ni
Dirksen, Anouk
Du, Bingfan
Duvall, Jeremy R.
Higgins, Stacy
Kozytska, Mariya V.
Bellovoda, Kamela
Faircloth, Chelsey
Lee, David
Li, Fu
Qin, Liuliang
Routhier, Caitlin
Shaw, Pamela
Stevenson, Cheri A.
Wang, Jason
Wongthida, Phonphimon
Ter-Ovanesyan, Elena
Ditty, Elizabeth
Bradley, Stephen P.
Xu, Ling
Yin, Mao
Yurkovetskiy, Alexandr V.
Mosher, Rebecca
Damelin, Marc
Lowinger, Timothy B.
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (09) : 999 - 1012
[7] A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression
Gitto, Sarah B.
Whicker, Margaret
Davies, Gareth
Kumar, Sushil
Kinneer, Krista
Lewis, Arthur
Mamidi, Srinivas
Medvedev, Sergey
Anderton, Judith
Tang, Jessica
Ferman, Benjamin
Coats, Steve
Wilkinson, Robert W.
Brown, Eric J.
Powell, Daniel J.
Simpkins, Fiona
CANCER RESEARCH, 2023, 83 (07)
[8] A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial
Ma, Yuxiang
Yang, Yunpeng
Huang, Yan
Fang, Wenfeng
Xue, Jinhui
Meng, Xiangjiao
Fan, Yun
Fu, Siqing
Wu, Lin
Zheng, Yulong
Liu, Jian
Liu, Zhihua
Zhuang, Wu
Rosen, Seth
Qu, Song
Li, Bihui
Li, Mingjun
Zhao, Yanqiu
Yang, Shujun
Ji, Yinghua
Sommerhalder, David
Luo, Suxia
Yang, Kunyu
Li, Jingao
Lv, Dongqing
Zhang, Peng
Zhao, Yuanyuan
Hong, Shaodong
Zhang, Yang
Zhao, Shen
Chin, Steve
Zhang, Xian
Lian, Wei
Cai, Jiaqiang
Xue, Tongtong
Zhang, Li
Zhao, Hongyun
NATURE MEDICINE, 2025,
[9] Antitumor effect of XMT1660, a B7H4 targeting antibody drug conjugate, in an unselected panel of patient derived xenograft models of breast cancer
Collins, Scott D.
Shaw, Pamela S.
Fessler, Shawn P.
Wang, Jason
Mosher, Rebecca
CANCER RESEARCH, 2022, 82 (12)
[10] A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression
Gitto, Sarah B.
Whicker, Margaret
Davies, Gareth
Kumar, Sushil
Kinneer, Krista
Xu, Haineng
Lewis, Arthur
Mamidi, Srinivas
Medvedev, Sergey
Kim, Hyoung
Anderton, Judith
Tang, E. Jessica
Ferman, Benjamin
Coats, Steven
Wilkinson, Robert W.
Brown, Eric
Powell, Daniel J.
Simpkins, Fiona
CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1567 - 1581

← 1 2 3 4 5 →